Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Y5VR
|
|||
| Former ID |
DIB004602
|
|||
| Drug Name |
H5N1 influenza vaccine
|
|||
| Synonyms |
Daronrix; GSK-1119711A; H5N1 influenza vaccine (inactivated whole virus adjuvanted); Avian influenzavaccine (inactivated whole virus adjuvanted), GlaxoSmithKline; H5N1 influenza vaccine (inactivated whole virus adjuvanted), GlaxoSmithKline
Click to Show/Hide
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Influenza virus infection [ICD-11: 1E30-1E32] | Phase 2 | [1] | |
| Company |
GlaxoSmithKline plc
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cell mediated immunity response (CMIR) | Target Info | . | [2], [3] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00430521) Safety & Immunogenicity of an Alternative Immunization Schedule of GSK Bio's Pandemic Influenza Vaccine (GSK1119711A). U.S. National Institutes of Health. | |||
| REF 2 | Anti-influenza agents from Traditional Chinese Medicine. Nat Prod Rep. 2010 Jan;27(12):1758-80. | |||
| REF 3 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.